eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2011
vol. 7
 
Share:
Share:

Original paper
A novel method of ultra-low contrast administration for coronarography and percutaneous coronary intervention using the automatic injector. The need to focus on contrast preservation techniques

Adam T. Stys
,
Tomasz Stys
,
Przemysław Recki

Post Kardiol Interw 2011; 7, 1 (23): 8-14
Online publish date: 2011/04/08
Article file
- A novel method.pdf  [1.08 MB]
Get citation
 
 

Introduction

The amount of administered intravascular contrast for invasive cardiac procedures corresponds to the risk of contrast-induced renal insufficiency (CIN) in multiple studies [1-4]. There has been considerable research towards prevention of CIN, though surprisingly contrast preservation studies seem to be relatively underrepresented in the literature. We would like to describe a protocol developed in our cath lab for coronary angiography and PCI in patients who are at higher risk of CIN. This protocol has been used by us since 2006 and has been designed for ultra-low contrast dosing with help of the automatic coronary injector (ACI). It has provided a basis for a reliably ultra-low dose of contrast administration per patient in our cath lab (often less than 10 ml per case). We present two cases to illustrate our protocol.

Method description

General approach

In patients with renal insufficiency we perform the procedures mostly via femoral access, as ultra-low administration of contrast seems to be easier to achieve in this setting. We often use long sheaths (35 cm or even longer), especially in percutaneous coronary intervention (PCI) cases, which translates into easier catheter manipulations and, in our experience, contrast savings. Biplane imaging is always used in cases of increased risk of CIN.

The initial assessment requires choice of catheters based on patients’ size, age, sex, and prior catheterization data. If applicable, prior angiography films are reviewed for catheter choices, including films obtained at other institutions. If there is a known proximal chronic total coronary occlusion in the past study, we usually do not inject this artery. In all cases we use low osmolar non-ionic contrast (iodixanol).

Catheter choice

In cases of coronary angiography, for the left coronary system, we use a 5 Fr JL 4.0 curve for medium and large sized individuals (height over 155 cm), and a 5 Fr JL 3.5 catheter for smaller individuals. For very small frame patients (weight below 45 kg, especially elderly females) we start with a 4 Fr JL 3.5 catheter. For the RCA, we routinely use 4 Fr 3DRC catheters, except for very large patients (weight over 130 kg, then a 5 Fr 3DRC catheter is used first). Most coronary angiograms can be performed using these catheters. For diagnostic catheterization, catheter sizes over 5 Fr are very rarely required. If the left coronary cannot be engaged with the JL 4.0 catheter, then the choice of the next catheter depends on the anatomy defined by control cineography with the injection as close to the ostium as possible (not more than 2 cc of contrast at flow of 3-5 ml/sec, 0.5 sec rise time). Typically larger or smaller JL curves and Amplatz curves are used then. Likewise, if the 3DRC catheter does not fit the RCA, then usually JR 4.0, multipurpose, or Amplatz curves are used.

In patients with a history of coronary artery bypass grafting the vein grafts are initially approached with a JR 4.0 5 Fr catheter, then if not successful a bypass left catheter (left system grafts) or multipurpose catheter (RCA grafts) is tried. The internal mammary artery (IMA) is engaged with a 4 Fr IMA catheter. We have not en­countered so far a case where a catheter larger than 4 Fr was needed for adequate opacification of the IMA.

Ostium engagement

Coronary ostium catheter engagement is a crucial step in contrast preservation. Attempts at coronary ostium catheter engagement often involve injection of a significant amount of contrast in the proximity of the ostium. We try to engage the ostia without applying any contrast, carefully watching the pressure wave on the catheter. The typical “jump” of classical coronary catheters as they enter the coronary ostia is anticipated. Once it is seen, then filling of the catheter with contrast is carefully done. The filing of the catheter is done knowing that its volume, on average, is about 2 ml. Settings of 2 ml, at 2 ml/sec, 0.2 sec rise time, and 300 psi, are routinely used. The “spill over” (should amount to about 0.5-1 ml of contrast) provides information for the initial automatic injector settings.

Automatic coronary injector programming

An automatic coronary injector (ACIST Medical Systems, Eden Prarie, MN) is used in all cases. It can be very precisely programmed by setting the volume of contrast per injection, flow, injection pressure, and rise time. Changing these settings dynamically during angiography is the basis for the minimization of contrast, without sacrificing the angiographic quality (fig. 1, 2).

Left coronary injection is obtained first in classical RAO caudal and LAO caudal (biplane) views. The information from filling of the catheter with contrast is used for setting the first set of ACI parameters. Typically, no more than 2 ml of contrast at 2 ml/sec is used for this injection, unless a very brisk flow in a large coronary system is noted. While this is a “scout” injection of the left system, it usually gives adequate information about the proximal parts of the left system, which these views are geared for. The next injection, in LAO and RAO cranial views, is set up usually with more volume (3-4 ml) as they give information on the more distal parts of the left system. The volume, flow and pressure settings are adjusted using the information from the first injection, i.e. if the coronary flow is brisk, then flow and/or pressure is increased (preferentially over the volume). Usually, these 4 views are sufficient (2 injections) for full assessment of the left coronary system.

The first RCA injection is also usually done with 2 ml of contrast at 2 ml/sec, 0.2 sec rise time, and pressure of 300 psi, unless the catheter filling shows higher than usual flow in the RCA, then we preferentially increase the flow and pressure over the volume. Straight LAO and cranial RAO biplane settings usually make one injection sufficient for RCA angiography. For high coronary flow cases the right amount of pressure and flow is sufficient to get the angiographic information even with 2 ml injection, especially if one examines the cine loop on a frame-by-frame basis. A maximum of 600 psi and rate up to 6 ml/sec are the usual safety limits we observe. We very rarely exceed 5 ml of contrast per injection.

The vein grafts are injected initially at 2 ml/sec for a total of 2 ml, 0.2 sec rise time, and 300 psi. Rarely higher settings are required for these and often flow rates as low as 1 ml/sec and total volume of 1 ml are sufficient.

The internal mammary artery injections are usually 2 ml total volume at 2 ml/sec, 0.2 sec rise time and 300 psi. Careful set up of the biplane cameras is necessary to be able to pan across the whole IMA and its grafted territory in both planes.

We routinely measure the left ventricular end-diastolic pressure in patients at increased risk for CIN, which gives us guidance on the hydration status. We act on this measurement while the patient is in the cath lab (more hydration or intravenous diuretic) and believe that this likely decreases the risk of CIN further.

Percutaneous coronary intervention

As usual, for PCI the choice of guide catheters depends on the angiography data. In general, more aggressive guides are used, as better support shortens the procedure, thus at least potentially decreasing contrast load. Also, with deeper sitting of guide catheters less contrast volume per injection is required. Thus, commonly EBU curves for the left and Amplatz curves for the RCA are used. Usually 6 Fr guides are used, unless a very simple PCI is anticipated, then a 5 Fr system is chosen. The PCI is done with contrast rate of administration and rate of rise low enough to minimize “back flow” of contrast into the aorta. Usually, 2 ml volume, 2 ml/sec flow and 0.2 sec rise time at 300-600 psi are sufficient. The guide wire and balloon/stent catheters inserted into the coronary centralize the guide tip, allowing for more efficient injections. For this reason, we avoid coronary injections through the guide catheter without at least partial guide wire insertion into the coronary artery. The guide wire passage is usually done without contrast, with the help of a memorized diagnostic angiogram, bony landmarks, as well as using coronary calcifications as a guide. The guide wire tip behaviour provides important information on its position. Most of the injections are recorded as cinegraphy runs, as they can be analysed, if necessary, beat by beat for further contrast savings.

Case studies

Case 1

An 84-year-old male with worsening heart failure and abnormal myocardial perfusion scan came for scheduled coronary angiography. The patient’s height was 175 cm and weight was 86.2 kg. Baseline creatinine clearance was 47 ml/min (creatinine of 1.43 mg/dl). The patient was pre-medicated with sodium bicarbonate infusion and N-acetylcysteine. A 5 Fr 35 cm long sheath was inserted into the right femoral artery. A JL 4.0 5 Fr diagnostic catheter was used for the left coronary angiography as described above. A 3DRC 4 Fr catheter was used for the RCA. Two left system injections (4 cine runs, biplane) were done with 2 ml volume, at 2 ml/sec with 0.2 sec rise time (fig. 3). One RCA injection (2 runs) was done with the same parameters as for the left system (fig. 4). A total of 8 ml of contrast was used for the whole procedure (4 ml for left, 2 ml for right coronary and 1 ml for catheter filling/spill over for each). Coronary angiograms have shown non-obstructive disease in RCA and distal significant disease in the left anterior descending artery (LAD). The creatinine clearance was 48 ml/min (creatinine of 1.40 mg/dl) one day after the procedure and 48 ml/min (creatinine of 1.4 mg/dl) 7 days after the procedure.

Case 2

An 88-year-old male presented for elective PCI of total chronic RCA in stent occlusion (fig. 5). The patient’s height was 180 cm and weight was 83.5 kg. Baseline creatinine clearance was 36 ml/min (creatinine of 1.66 mg/dl). Three weeks before, he had undergone complex LAD stenting in the setting of non-ST elevation myocardial infarction. A 6 Fr 35 cm sheath was inserted into the right femoral artery. A 6 Fr AL 0.75 guide catheter was used to engage the RCA ostium and initially a BMW guide wire was tried unsuccessfully to cross the occlusion, relying mostly on the calcium print of the artery. Then a Pilot 50 wire was used successfully to cross the lesion. The deep intubation of the RCA with the guide catheter allowed for the 1 ml/sec, 1 ml total volume, 0.2 sec rise time (600 psi) injections that were diagnostic. After multiple pre-dilations with a 2.0 × 30 mm balloon in the distal, mid, and proximal RCA, stenting was done with two 2.5 × 28 mm Xience V stents starting distally, then 3.0 × 28 mm and 3.0 × 23 mm Xience V stents up to the proximal vessel. A good result was obtained (fig. 6, 7). A total of 9 ml of contrast was used for the procedure. The creatinine clearance was 41 ml/min (creatinine of 1.48 mg/dl) one day after the procedure and 38 ml/min (creatinine of 1.6 mg/dl) 7 days after the procedure.

Discussion

Contrast minimization is becoming a greater necessity as the patient population for invasive cardiac procedures becomes older and more complex, and thus at higher risk of CIN. Also, decreased contrast use should save money. The most effective, so far, pharmacological method of prevention of CIN tested in larger populations is hydration with sodium bicarbonate and N-acetylcysteine admi­nistration [5]. This method and others are not very robust in decreasing CIN. Contrast preservation is the first and probably most important step in reducing CIN.

Our method is based on carefully following the proto­col, designed for a biplane lab and based on the use of ACI. The ACI settings are based on the preferential use of higher flow and pressure over the volume of contrast per injection. In our experience, the accurately programmed flow and pressure settings for a bolus of contrast are more important than the absolute volume. With the right settings of the ACI, one can literally follow the contrast bolus frame by frame on review of films, achieving the full diagnostic potential (fig. 6, 7).

A recent publication described manual injections of ultra-low contrast volumes for coronary procedures [6]. We have been applying some of the techniques described in this report; however, we do not use intravascular ultrasound routinely, as a contrast saving tool. In our experience, the addition of ACI to our protocol drastically saves on the contrast volume to the point that contrast exposure might possibly become a negligible risk when it comes to CIN. Importantly, automatic injections also decrease the uncertainty factor, in view of the individual variations in dynamics of manual contrast administration (both intra- and inter-operator). Standardized injections by ACI are easier to introduce and teach throughout the cardiology community for the benefit of our patients.

Automatic injectors have been shown to improve the quality of angiography through smaller catheters (i.e. 4 Fr) and reduce patient contrast dose and fluoroscopy time [7, 8]. They allow for monitoring of pressure at the catheter tip and have the inbuilt safety feature of response to the intensity of the operator’s pressure on the control handle. Thus, ACI use could be safer and could improve image quality, in addition to saving on the contrast volume, compared to manual injections [9].

The choice of catheters depending on patient characteristics has helped us minimize contrast volume. The smaller the internal lumen of the catheter, the less contrast one might expect to use per injection. However, in larger individuals, requiring higher rates and volumes of administration, 4 Fr catheters for the left coronary artery might be impractical, as they will have a tendency to prolapse out of the coronary with the pressure delivered and also their use might not achieve full opacification.

The learning curve for our protocol is not steep, the biggest challenge being the cannulation of coronary ostia with a minimal amount or without contrast. Achieving coaxial alignment of the catheter in the coronary also helps in contrast preservation. Coronary ostium engagement is the most operator-dependent step; however, these techniques are taught in every cardiology fellowship. The individual further adjustments of the injection parameters after the initial injection also require some experience; however, they are quite intuitive, and thus easy to master.

Conclusions

Intravascular contrast administration using our ACI protocol allows for ultra-low volumes of contrast per coronary case, aimed at reducing the risk of CIN. The protocol standardization makes it easy to teach and disseminate through the cardiology community. We think that the use of appropriately programmed ACI is essential in reducing contrast load for coronary percutaneous procedures. We believe that it is high time to go back to the basics and focus more on contrast preservation techniques, rather than chase the so far elusive goal of ideal CIN protective medication(s).

References

1. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399.

2. Dangas G, Iakovu I, Nikolsky E, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Coll Cardiol 2005; 95: 13-19.

3. Weisbord SD, Mor MK, Resnik, MA, et al. Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med 2008; 168: 1325-1332.

4. Kane GC, Doyle BJ, Lerman A, et al. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol 2008; 51: 89-92.

5. Brown JR, Block CA, Malenka DJ, et al. Sodium Bicarbonate plus N-acetylcysteine prophilaxis: meta-analysis. J Am Coll Cardiol Intv 2009; 2: 1116-1124.

6. Nayak KR, Mehta HS, Price MJ, et al. A novel Technique for Ultra-Low Contrast Administration During Angiography or Intervention. Cathet Cardiovasc Interv 2010; 75: 1076-1083.

7. Anne G, Gruberg L, Huber A, et al. Traditional versus automated injection contrast system in diagnostic and percutaneous coronary interventional procedures: Comparison of the contrast volume delivered. J Invasive Cardiol 2004; 16: 360-362.

8. Khoukaz S, Kern MJ, Bitar SR, et al. Coronary angiography using 4 Fr catheters with assisted automated injection: A randomized comparison to 6 Fr manual technique and early ambulation. Cathet Cardiovasc Interv 2001; 52: 393-389.

9. Kaluski E, Moussa ID, Heuser RR, et al. Automated Contrast Injectors for Angiography : Devices, Methodology, and Safety. Cathet Cardiovas Interv 2009; 74: 459-464.
Copyright: © 2011 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.